GRI Bio recently underwent a 1/30 split on April 24th, accompanied by a merger/restructure of Vallon Pharmaceuticals. The stock price immediately tanked approx. 50% in the following days. The price has held above the low of $5.50 on April 26th for over a month. Based on past performance, this stock has a tendency to jump 30 to >200% in a single day. GRI Bio has touted the merger and restructuring will bring "near term" value to stock holders, and perhaps a catalyst will emerge in the coming month(s). I think this is a safe long with stops at $5.50 or thereabouts. A jump to $10 or higher seems reasonable, but will likely retrace immediately.
GRI Bio to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Thursday, June 22, 2023 at 12:00 PM ET quantisnow.com/insight/4645144
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.